Blood safety and the choice of anti-hemophilic factor concentrate.
Janco
Robert L
RL
D001782:Blood Donors; D017848:Blood-Borne Pathogens; D005164:Factor IX / Q000009:adverse effects / Q000627:therapeutic use; D005169:Factor VIII / Q000009:adverse effects / Q000627:therapeutic use; D006467:Hemophilia A / Q000628:therapy; D006801:Humans; D012307:Risk Factors; D012449:Safety; D014777:Virus Diseases / Q000517:prevention & control*; D038301:Virus Inactivation
D005169:Factor VIII; D005164:Factor IX